Abstract
We examined the mechanism by which estrogen regulates telomerase activity in Caov-3 human ovarian cancer cell lines, which express ER, to determine whether the regulation affects the expression and/or phosphorylation of the telomerase catalytic subunit (hTERT). 17β-Estradiol (E2) induced telomerase activity and hTERT expression. Transient expression assays using luciferase reporter plasmids containing various fragments of hTERT promoter showed that the estrogen-responsive element appeared to be partially responsible for the E2-induced activation of the hTERT promoter. Either pretreatment with a phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, or transfection with a dominant-negative Akt attenuated the E2-induced activation of the hTERT promoter. In addition, estrogen induced the phosphorylation of IκB inhibitor protein via the Akt cascade, and cotransfection with a dominant-negative subunit of NFκB attenuated the response of the ERE-deleted hTERT promoter to E2. Moreover, E2 induced the phosphorylation of hTERT, the association of 14-3-3 protein and NFκB with hTERT, and nuclear accumulation of hTERT in an Akt-dependent manner. These results indicate that E2 induces telomerase activity not only by transcriptional regulation of hTERT via an ERE-dependent mechanism and a PI3K/Akt/NFκB cascade, but also by post-transcriptional regulation via Akt-dependent phosphorylation of hTERT. Thus, the phosphorylation of Akt is a key event in the induction of telomerase activity by E2 in human ovarian cancer cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Akalin A, Elmore LW, Forsythe HL, Amaker BA, McCollum ED, Nelson PS, Ware JL and Holt SE . (2001). Cancer Res., 61, 4791–4796.
Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC and Anderson KC . (2002). Cancer Res., 62, 3876–3882.
Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC and Anderson KC . (2003). Cancer Res., 63, 18–21.
Alfonso-De Matte MY, Yang H, Evans MS, Cheng JQ and Kruk PA . (2002). Cancer Res., 62, 4575–4578.
Baeuerle PA and Baltimore D . (1996). Cell, 87, 13–20.
Boldrini L, Faviana P, Gisfredi S, Zucconi Y, Di Quirico D, Donati V, Berti P, Spisni R, Galleri D, Materazzi G, Basolo F, Miccoli P, Pingitore R and Fontanini G . (2002). Int. J. Oncol., 21, 493–497.
Bourgarel-Rey V, Vallee S, Rimet O, Champion S, Braguer D, Desobry A, Briand C and Barra Y . (2001). Mol. Pharmacol., 59, 1165–1170.
Breitschopf K, Zeiher AM and Dimmeler S . (2001). FEBS Lett., 493, 21–25.
Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, Barone MV and Auricchio F . (2001). EMBO J., 20, 6050–6059.
Chen FE, Huang DB, Chen YQ and Ghosh G . (1998). Nature, 391, 410–413.
Chomczynski P and Sacchi N . (1987). Anal. Biochem., 162, 156–159.
Chow SN, Chien CH and Chen CT . (1996). Int. Surg., 81, 152–157.
Cong YS, Wen J and Bacchetti S . (1999). Hum. Mol. Genet., 8, 137–142.
Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME . (1997). Cell, 91, 231–241.
Greider CW and Blackburn EH . (1985). Cell, 43, 405–413.
Greider CW and Blackburn EH . (1989). Nature, 337, 331–337.
Harley CB and Villeponteau B . (1995). Curr. Opin. Genet. Dev., 5, 249–255.
Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Kanzaki T and Murata Y . (2000). Cancer Res., 60, 5988–5994.
Hisamoto K, Ohmichi M, Kanda Y, Adachi K, Nishio Y, Hayakawa J, Mabuchi S, Takahashi K, Tasaka K, Miyamoto Y, Taniguchi N and Murata Y . (2001a). J. Biol. Chem., 276, 47642–47649.
Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N and Murata Y . (2001b). J. Biol. Chem., 276, 3459–3467.
Holt SE, Aisner DL, Baur J, Tesmer VM, Dy M, Ouellette M, Trager JB, Morin GB, Toft DO, Shay JW, Wright WE and White MA . (1999). Genes. Dev., 13, 817–826.
Kanaya T, Kyo S, Takakura M, Ito H, Namiki M and Inoue M . (1998). Int. J. Cancer, 78, 539–543.
Kang SS, Kwon T, Kwon DY and Do SI . (1999). J. Biol. Chem., 274, 13085–13090.
Kawagoe J, Ohmichi M, Takahashi T, Ohshima C, Mabuchi S, Takahashi K, Igarashi H, Mori-Abe A, Saitoh M, Du B, Ohta T, Kimura A, Kyo S, Inoue M and Kurachi H . (2003). J. Biol. Chem., 279, 43363–43372.
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW . (1994). Science, 266, 2011–2015.
Kraemer K, Fuessel S, Schmidt U, Kotzsch M, Schwenzer B, Wirth MP and Meye A . (2003). Clin. Cancer Res., 10, 3794–3800.
Kyo S, Kanaya T, Takakura M, Tanaka M and Inoue M . (1999a). Int. J. Cancer, 80, 60–63.
Kyo S, Kanaya T, Takakura M, Tanaka M, Yamashita A, Inoue H and Inoue M . (1999b). Int. J. Cancer, 80, 804–809.
Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A and Inoue M . (1999c). Cancer Res., 59, 5917–5921.
Lacey Jr JV, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A and Schairer C . (2002). JAMA, 288, 334–341.
Li H, Zhao L, Yang Z, Funder JW and Liu JP . (1998). J. Biol. Chem., 273, 33436–33442.
Li H, Zhao LL, Funder JW and Liu JP . (1997). J. Biol. Chem., 272, 16729–16732.
Liu JP . (1999). FASEB J., 13, 2091–2104.
Liu K, Hodes RJ and Weng N . (2001). J. Immunol., 166, 4826–4830.
Mabuchi S, Ohmichi M, Kimura A, Hisamoto K, Hayakawa J, Nishio Y, Adachi K, Takahashi K, Arimoto-Ishida E, Nakatsuji Y, Tasaka K and Murata Y . (2002). J. Biol. Chem., 277, 33490–33500.
Maida Y, Kyo S, Kanaya T, Wang Z, Yatabe N, Tanaka M, Nakamura M, Ohmichi M, Gotoh N, Murakami S and Inoue M . (2002). Oncogene, 21, 4071–4079.
Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA and Weinberg RA . (1997). Cell, 90, 785–795.
Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C and Auricchio F . (2000). EMBO J., 19, 5406–5417.
Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E and Auricchio F . (1996). EMBO J., 15, 1292–1300.
Misiti S, Nanni S, Fontemaggi G, Cong YS, Wen J, Hirte HW, Piaggio G, Sacchi A, Pontecorvi A, Bacchetti S and Farsetti A . (2000). Mol. Cell. Biol., 20, 3764–3771.
Moorhead G, Douglas P, Morrice N, Scarabel M, Aitken A and MacKintosh C . (1996). Curr. Biol., 6, 1104–1113.
Murakami J, Nagai N, Ohama K, Tahara H and Ide T . (1997). Cancer, 80, 1085–1092.
Nakano K, Watney E and McDougall JK . (1998). Am. J. Pathol., 153, 857–864.
Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Ide T and Ishikawa F . (1998). Nat. Genet., 18, 65–68.
Ohmichi M, Matuoka K, Takenawa T and Saltiel AR . (1994). J. Biol. Chem., 269, 1143–1148.
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM and Donner DB . (1999). Nature, 401, 82–85.
Park TW, Riethdorf S, Riethdorf L, Loning T and Janicke F . (1999). Int. J. Cancer, 84, 426–431.
Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T and Gerritsen ME . (1997). J. Biol. Chem., 272, 21096–21103.
Romashkova JA and Makarov SS . (1999). Nature, 401, 86–90.
Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, Yamane K and Tsuruo T . (2000). EMBO J., 19, 2652–2661.
Shay JW and Bacchetti S . (1997). Eur. J. Cancer, 33, 787–791.
Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW and Liao JK . (2000). Nature, 407, 538–541.
Takakura M, Kyo S, Kanaya T, Tanaka M and Inoue M . (1998). Cancer Res., 58, 1558–1561.
Taniguchi T, Endo H, Chikatsu N, Uchimaru K, Asano S, Fujita T, Nakahata T and Motokura T . (1999). Blood, 93, 4167–4178.
Teng L, Specht MC, Barden CB and Fahey III TJ . (2003). J. Clin. Endocrinol. Metab., 88, 1362–1366.
Wang Z, Kyo S, Takakura M, Tanaka M, Yatabe N, Maida Y, Fujiwara M, Hayakawa J, Ohmichi M, Koike K and Inoue M . (2000). Cancer Res., 60, 5376–5381.
Wang Z, Kyo S, Maida Y, Takakura M, Tanaka M, Yatabe N, Kanaya T, Nakamura M, Koike K, Hisamoto K, Ohmichi M and Inoue M . (2002). Oncogene, 21, 3517–3524.
Wick M, Zubov D and Hagen G . (1999). Gene, 232, 97–106.
Yang J, Winkler K, Yoshida M and Kornbluth S . (1999). EMBO J., 18, 2174–2183.
Yeilding NM, Rehman MT and Lee WM . (1996). Mol. Cell. Biol., 16, 3511–3522.
Yin L, Hubbard AK and Giardina C . (2000). J. Biol. Chem., 275, 36671–36675.
Acknowledgements
We are grateful to Dr Takashi Tsuruo (Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan) for providing pCR3 vector, pCR3-hTERT-HA, and GST-14-3-3-3θ constructs, Dr Gourisankar Ghosh (Department of Chemistry and Biochemistry, University of California, San Diego, USA) for providing pCR-FLAG-p50 and pCR-FLAG-p50ΔNLS constructs, Dr Michael E Greenberg and Dr Sandeep R Datta (Children's Hospital and Department of Neurobiology, Harvard Medical School, Boston, USA) for the gift of the vectors encoding the various forms of Akt.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kimura, A., Ohmichi, M., Kawagoe, J. et al. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 23, 4505–4515 (2004). https://doi.org/10.1038/sj.onc.1207582
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207582
Keywords
This article is cited by
-
Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer
Cancer Cell International (2022)
-
Association between prediagnostic leukocyte telomere length and breast cancer risk: the Singapore Chinese Health Study
Breast Cancer Research (2019)
-
Low-dose levels of bisphenol A inhibit telomerase via ER/GPR30-ERK signalling, impair DNA integrity and reduce cell proliferation in primary PBMC
Scientific Reports (2017)
-
Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia
Molecular Biology Reports (2014)
-
Human telomerase activity regulation
Molecular Biology Reports (2011)